We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Oral Bacteria Found in Cerebral Emboli of Stroke Patients

By LabMedica International staff writers
Posted on 05 Jun 2019
In addition to traditional causative factors, such as hypertension, hypercholesterolemia, diabetes mellitus, smoking, and obesity, bacterial inflammation has been suggested to contribute directly or indirectly to the development of the atherosclerosis and atherothrombotic events.

Chronic infections have been reported to be risk factors for both coronary heart disease and ischemic stroke. More...
DNA of oral bacteria, mainly from the viridans streptococci group, has been detected in coronary thrombus aspirates of myocardial infarction and cerebral aneurysms. Cerebral artery thrombosis causes 87 % of strokes. Most thrombi originate in carotid artery stenoses from where they travel to block cerebral circulation.

Scientists from the University of Tampere (Tampere, Finland) analyzed thrombus aspirates, which neurointerventional radiologists removed from 75 stroke patients (69% men; mean age, 67 years), as part of emergency treatment. Bacterial DNA was extracted from samples using a commercially available QIAamp DNA Mini Kit.

Universal bacterial primers and probe24 were determined with RNaseP. The presence of Streptococcus species, mainly the Streptococcus mitis group, belonging to viridans streptococci as well as Porphyromonas gingivalis and Aggregatibacter actinomycetemcomitans in samples were determined using a quantitative polymerase chain reaction (qPCR) with specific primers and probes. The qPCR assays were performed using specific TaqMan allele hybridization with the AbiPrism 7900 HT Sequence Detection System.

The team reported that bacterial DNA was detected in 63 (84%) of aspired thrombi, and 12 (16%) of samples were considered bacterial DNA negative. DNA of Streptococcus species, mainly the S. mitis group, was found in 59 (79%) of samples. The median relative amount of Streptococcus species DNA was more than 5‐fold higher compared with the control blood samples from the same patients. All thrombi were negative for both P. gingivalis and A. actinomycetemcomitans.

The authors conclude that they had found DNA of Streptococcus species, mainly the S. mitis group, belonging to viridans streptococci, in most aspirated thrombi of the patients with Acute ischemic stroke (AIS). This suggests that viridans streptococci may have a role in the cause of cerebrovascular disease. Regular dental care should be emphasized in the primary prevention of AIS. The study was published on June 4, 2019, in the Journal of American Heart Association.

Related Links:
University of Tampere


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Blood-Based Protein Biomarker Solution for Alzheimer's Disease
BG-DTi2000.
Automated Clinical Chemistry Analyzer
Envoy 500+
Gold Member
POCT RT-qPCR Analyzer
BG-X6
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Technology

view channel
Image: The laser-based photoacoustic spectroscopy setup consists of a Mid-IR laser equipped with three QCL modules covering wavelengths from 5.6 μm to 12.9 μm, two silver coated mirrors (SCM), a dichroic mirror (DM) with a transmittance of 90%, a thermal power sensor head (PM) to monitor the output laser power, a mechanical chopper (MC) for frequency modulation and a CEPAS-detector with a self-designed swab holder (SH). (Credit: Graunke, T., Scholz, T., Pieniak, M. et al. Scientific Reports (2026). https://doi.org/10.1038/s41598-026-68298-9)

Laser-Based Swab Analysis Shows Promise for Detecting Disease-Linked Odor Patterns

Disease-related changes in volatile organic compounds can alter body odor, producing measurable patterns in exhaled breath and bodily fluids. Current analytical methods can be complex, time-consuming,... Read more

Industry

view channel
Image: TruVerus is designed to deliver a broad menu of routine blood tests from a small blood sample on a single, automated benchtop platform (Photo courtesy of Truvian Health)

Collaboration Advances Automated Benchtop Platform for Routine Blood Testing

Routine blood testing is central to clinical decision-making, but access can vary across laboratory and healthcare settings. Broader use of automated benchtop platforms may help integrate testing more... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.